- Service Details

Quotient has the experience & expertise to seamlessly deliver your studies with the highest quality service & speed to clinical data. If you need a complete service including data management, analysis, statistics, medical writing, Quotient is your answer.

- Service Details

In response to a growing interest in conducting human 14C-radiolabeled ADME studies earlier in drug development, Celerion has expanded its ADME suite in Lincoln, Nebraska.

- Service Details

Quotient has the experience and expertise to seamlessly deliver several studies involving Bioavailability, dose proportionality, absolute bioavailability, Bioequivalence, 14C ADME / Mass Balance, Thorough QT (TQT) / cardiac safety, Pharmacodynamics etc.

- Service Details

Chiltern provides the following services for Phase llb - III Late-stage programs: Protocol feasibility and design, CRF development, Recruitment, Data management, Medical writing, Biostatistics, Drug safety monitoring committees

- Service Details

Program services offered by both clinics range from medical writing, clinical conduct and data management to monitoring, biostatistics and clinical pharmacology.

- Service Details

MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification

- Service Details

MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification

- Service Details

Celerion’s clinic in Lincoln, Nebraska, is the only Phase I facility in North America with proven experience to release radiolabeled drug to regulatory standards that has been formulated on site for intravenous use in humans. This is required to perform assessments of absolute bioavailability

- Service Details

With over 40 years of experience, more than 600 beds in North America and Europe, Celerion offers the largest global Phase I and II clinical operations networks in the industry.

- Service Details

PAREXEL’s global team of experienced clinical pharmacokineticists and pharmacometricians offer unsurpassed expertise in Clinical PK/PD and Pharmacometrics, from pre-clinical to Phase III studies.

- Service Details

With more than 40 years of experience in performing bioequivalence studies, our clinical unit in Bloemfontein, South Africa, is a center of excellence. It is strategically placed in the perfect location for these trials a lower cost and fast start-up environment.

- Service Details

We have a speciality in early phase trials involving healthy volunteers. Early phase trials may have many factors that must be considered to achieve the research goals.

- Service Details

PAREXEL® has the global SOPs to perform Phase 1 clinical trials in harmony across multiple locations, and stands committed to the success of your journey.

- Service Details

PPD’s Phase I clinic conducts approximately 100 studies per year and has sufficient capacity to carry out multiple studies of varying design simultaneously. Research-experienced, board-certified physicians serve as principal investigators for Phase I studies. Secure and confidential drug

- Service Details

The ADME (Absorption, Distribution, Metabolism and Excretion) Suite includes new state-of-the-art equipment and laboratory space to perform on-site scintillation counting allowing for radioactivity recovery results to be delivered in real-time.

- Service Details

PAREXEL® has developed an integrated and adaptive approach that supports Phase IIa outcomes.

- Service Details

Our team understands that upfront planning is critical for the success of every clinical trial and that planning must be produced in cooperation with your clinical team.

- Service Details

Nuvisan Clinical Development offers various clinical services including Studies with biologicals, Drug/Drug interaction studies, Food effect studies, Bioavailability & Bioequivalence Studies, Phase IIa, Proof of Concept studies special patient populations

- Service Details

Nuvisan supports you with DMPK/ADME services throughout the discovery & development phases including Tailor-made “phase 0” in vitro & in vivo packages, i.e. in vitro metabolism, CYP interactions, absorption, distribution, PK/ADME in rodents & non-rodents.

- Service Details

Azidus has experienced team of professionals to handle the all phases of drug development from Phase I to Phase IV clinical trials. The technical team can design & execute the phase trials at committed time as per the International regulatory guidelines.

- Service Details

We have capabilities to conduct Phase I Studies on Healthy Volunteers & offers Phase I studies for NCEs & NBEs. We also offer services on clinical pharmacology studies including Food Effect, Drug Interaction studies, PK/PD studies, studies for biomarkers.

- Service Details

Bluepharma performs its activity from product development to the end of the value chain, that is, finished product supply.

- Service Details

Frequently, our Clients find their commercial dosage form is not appropriate for non-clinical testing. For developers in need of formulations specifically for toxicology and/or pharmacokinetic studies, we have the solution.